When did VANDA PHARMACEUTICALS INC (VNDA) report earnings last quarter?
VANDA PHARMACEUTICALS INC (VNDA) last reported earnings on 2/11/2026.
VANDA PHARMACEUTICALS INC (VNDA) Earnings History & Surprises
NASDAQ:VNDA • US9216591084
Current stock price
8.81 USD
-0.48 (-5.17%)
At close:
8.9392 USD
+0.13 (+1.47%)
After Hours:
VNDA Earnings overview
Past quarterly earnings results for VANDA PHARMACEUTICALS INC (VNDA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.74
- Revenue Estimate
- 55.361M
Last Reported
Most Recent- Release Date
- Feb 11, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.46
- EPS Surprise
- 65.96%
- Revenue Surprise
- -5.37%
Beat Rate
Last 8 Quarters 50%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.46 | -1.35 | 65.96% | -475.00% | 57.216M | 60.461M | -5.37% | 7.58% |
| Q3 2025 | -0.38 | -0.46 | 17.82% | -322.22% | 56.258M | 59.908M | -6.09% | 18.06% |
| Q2 2025 | -0.46 | -0.36 | -26.44% | -475.00% | 52.59M | 55.689M | -5.56% | 4.19% |
| Q1 2025 | -0.50 | -0.61 | 17.84% | -614.29% | 50.041M | 46.037M | 8.70% | 5.44% |
| Q4 2024 | -0.08 | -0.11 | 26.47% | -100.00% | 53.185M | 53.293M | -0.20% | 17.48% |
| Q3 2024 | -0.09 | -0.17 | 45.98% | - | 47.651M | 50.138M | -4.96% | 22.76% |
| Q2 2024 | -0.08 | -0.21 | 62.65% | -366.67% | 50.474M | 48.817M | 3.39% | 9.59% |
| Q1 2024 | -0.07 | 0.05 | -237.25% | -216.67% | 47.46M | 49.47M | -4.06% | -24.06% |
| Q4 2023 | -0.04 | -0.09 | 56.43% | -133.33% | 45.271M | 37.74M | 19.95% | -29.79% |
| Q3 2023 | 0.00 | -0.04 | 100.00% | -100.00% | 38.815M | 45.39M | -14.49% | -40.58% |
| Q2 2023 | 0.03 | -0.13 | 122.62% | -40.00% | 46.056M | 49.98M | -7.85% | -28.47% |
| Q1 2023 | 0.06 | - | 154.55% | 62.5M | - | 3.84% | ||
| Q4 2022 | 0.12 | 0.08 | 47.06% | - | 64.48M | 68.952M | -6.49% | -5.20% |
| Q3 2022 | 0.06 | 0.09 | -34.64% | -57.14% | 65.32M | 72.42M | -9.80% | -6.82% |
| Q2 2022 | 0.05 | 0.14 | -64.99% | -70.59% | 64.39M | 68.34M | -5.78% | -5.17% |
| Q1 2022 | -0.11 | -0.01 | -978.43% | -173.33% | 60.19M | 59.16M | 1.74% | -3.96% |
| Q4 2021 | 0.12 | 0.09 | 38.41% | -20.00% | 68.02M | 71.441M | -4.79% | 0.55% |
| Q3 2021 | 0.14 | 0.18 | -23.75% | 27.27% | 70.1M | 75.735M | -7.44% | 16.23% |
| Q2 2021 | 0.17 | 0.14 | 19.05% | 6.25% | 67.9M | 71.145M | -4.56% | 9.15% |
| Q1 2021 | 0.15 | 0.15 | -1.96% | 1,400.00% | 62.67M | 69.87M | -10.30% | 8.05% |
| Q4 2020 | 0.15 | 0.14 | 8.13% | - | 67.65M | 65.28M | 3.63% | - |
| Q3 2020 | 0.11 | 0.10 | 13.13% | - | 60.31M | 65.229M | -7.54% | - |
| Q2 2020 | 0.16 | 0.04 | 259.20% | - | 62.21M | 63.189M | -1.55% | - |
| Q1 2020 | 0.01 | 0.00 | 460.22% | - | 58M | 58.004M | -0.01% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
18.80%
Max EPS beat (4)
65.96%
Min EPS beat (4)
-26.44%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-2.08%
Max Revenue beat (4)
8.70%
Min Revenue beat (4)
-6.09%
Analysis
In the last 4 quarters, VNDA has beaten EPS estimates in 3 out of 4 releases
VNDA has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, VNDA has beaten the EPS estimates by 18.8% on average.
In the last 4 quarters, VNDA reported -2.1% below the revenue estimates on average.
Related analysis
VANDA PHARMACEUTICALS INC / VNDA Earnings FAQ
Did VANDA PHARMACEUTICALS INC (VNDA) beat earnings estimates last quarter?
VANDA PHARMACEUTICALS INC (VNDA) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does VNDA stock beat earnings estimates?
In the last 4 quarters, VANDA PHARMACEUTICALS INC (VNDA) has beaten EPS estimates in 3 out of 4 releases.